Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
US Department of Justice
Boehringer Ingelheim
Chubb
Mallinckrodt
Federal Trade Commission
Moodys
Fish and Richardson

Generated: August 17, 2018

DrugPatentWatch Database Preview

Jazz Pharms Iii Company Profile

« Back to Dashboard

What is the competitive landscape for JAZZ PHARMS III, and when can generic versions of JAZZ PHARMS III drugs launch?

JAZZ PHARMS III has one approved drug.

There are two US patents protecting JAZZ PHARMS III drugs.

There are thirteen patent family members on JAZZ PHARMS III drugs in nine countries.

Summary for Jazz Pharms Iii
International Patents:13
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Jazz Pharms Iii

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-005 Jul 9, 2010 AB RX Yes No 6,024,981 ➤ Try a Free Trial Y ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-003 Jun 3, 2005 DISCN No No 6,024,981 ➤ Try a Free Trial Y ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-004 May 30, 2007 AB RX Yes No 6,221,392 ➤ Try a Free Trial Y ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-001 Feb 10, 2004 AB RX Yes No 6,024,981 ➤ Try a Free Trial Y ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-001 Feb 10, 2004 AB RX Yes No 6,221,392 ➤ Try a Free Trial Y ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-005 Jul 9, 2010 AB RX Yes No 6,221,392 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Jazz Pharms Iii

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-002 Feb 10, 2004 6,024,981 ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-005 Jul 9, 2010 6,106,861 ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-003 Jun 3, 2005 6,106,861 ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-002 Feb 10, 2004 6,106,861 ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-004 May 30, 2007 5,178,878 ➤ Try a Free Trial
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-006 Jul 9, 2010 6,221,392 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Jazz Pharms Iii Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Julphar
Moodys
Daiichi Sankyo
Medtronic
Federal Trade Commission
Healthtrust
Mallinckrodt
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.